MTOR and hepatocellular carcinoma: Similarly, AMSC-EVs facilitate the transfer of miR-199a to HCC, thereby enhancing the sensitivity of HCC cells to the chemotherapy agent DOX by regulating the mTOR pathway, both in cellular and animal models101.